Cargando…
Disease progression joint model predicts time to type 1 diabetes onset: Optimizing future type 1 diabetes prevention studies
Clinical trials seeking type 1 diabetes prevention are challenging in terms of identifying patient populations likely to progress to type 1 diabetes within limited (i.e., short‐term) trial durations. Hence, we sought to improve such efforts by developing a quantitative disease progression model for...
Autores principales: | Morales, Juan Francisco, Muse, Rhoda, Podichetty, Jagdeep T., Burton, Jackson, David, Sarah, Lang, Patrick, Schmidt, Stephan, Romero, Klaus, O'Doherty, Inish, Martin, Frank, Campbell‐Thompson, Martha, Haller, Michael J., Atkinson, Mark A., Kim, Sarah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10349195/ https://www.ncbi.nlm.nih.gov/pubmed/37186151 http://dx.doi.org/10.1002/psp4.12973 |
Ejemplares similares
-
Leveraging Real‐World Data for EMA Qualification of a Model‐Based Biomarker Tool to Optimize Type‐1 Diabetes Prevention Studies
por: Podichetty, Jagdeep T., et al.
Publicado: (2022) -
The pancreas in human type 1 diabetes
por: Rowe, Patrick A., et al.
Publicado: (2010) -
Open Data Revolution in Clinical Research: Opportunities and Challenges
por: Shahin, Mohamed H., et al.
Publicado: (2020) -
Serum Trypsinogen Levels in Type 1 Diabetes
por: Li, Xia, et al.
Publicado: (2017) -
Acute Versus Progressive Onset of Diabetes in NOD Mice: Potential Implications for Therapeutic Interventions in Type 1 Diabetes
por: Mathews, Clayton E., et al.
Publicado: (2015)